Open-Label Extension of the Phase III Study With Tramiprosate (3APS) in Patients With Mild to Moderate Alzheimer's Disease
Clinical trial NCT00314912 · UNKNOWN
Trial details
- NCT number
- NCT00314912
- Sponsor
- Bellus Health Inc. - a GSK company
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Enrollment
- 650
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.